Dr. Shirai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Dartmouth-Hitchcock Medical Center
One Medical Center Drive
Lebanon, NH 03756- Is this information wrong?
Education & Training
- Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 2005 - 2008
- UPMC Medical EducationResidency, Internal Medicine, 2002 - 2005
- Faculty of Medicine Kyoto UniversityClass of 1997
Certifications & Licensure
- NH State Medical License 2015 - 2025
- VT State Medical License 2023 - 2024
- SC State Medical License 2005 - 2017
- PA State Medical License 2002 - 2005
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer Start of enrollment: 2007 Jun 04
- Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers Start of enrollment: 2009 Nov 01
- Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2009 Dec 16
- Join now to see all
Publications & Presentations
PubMed
- Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series.John P Palmer, Arief A Suriawinata, Shaofeng Yan, Darcy A Kerr, Muhammad Z Afzal, Keisuke Shirai> ;The American Journal of Case Reports. 2023 Nov 18
- Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors.Yuanzhen Cao, Muhammad Zubair Afzal, Keisuke Shirai, Gutmann, E.> ;Melanoma Research. 2024 Feb 1
- 1 citationsSociety for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, Diwakar Davar, Geoffrey T Gibney, Omid Hamid, Tina J Hieken, Benjamin Izar, Douglas B Johnson, Rajan P Kulk...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
- Join now to see all
Press Mentions
- Resident and Circulating Memory T Cells Persist for Years in Melanoma Patients with Durable Responses to ImmunotherapyMarch 24th, 2021
- At the Hospitals: Aug. 18, 2019August 17th, 2019
- Dartmouth-Hitchcock Health Funds $1M Annually for Dedicated Cancer Clinician Research TimeJuly 31st, 2019
Professional Memberships
- Member
Hospital Affiliations
- Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: